These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6689343)

  • 21. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human killer cells and natural killer cells: distinct subpopulations of Fc receptor-bearing lymphocytes.
    Neville ME
    J Immunol; 1980 Dec; 125(6):2604-9. PubMed ID: 6776195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Case of pernicious anemia with immunodeficiency, improved after administration of vitamin B12].
    Matsuzaki H; Kawano F; Oda T; Tomino S; Takatsuki K
    Rinsho Ketsueki; 1983 Jan; 24(1):39-44. PubMed ID: 6842832
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary deficiency of K cells in a normal subject.
    Portaro JK; Zighelboim J; Fahey JL
    Clin Immunol Immunopathol; 1978 Dec; 11(4):458-69. PubMed ID: 729212
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased 'killer' cells in Graves' disease.
    Pozzilli P; Andreani D
    Horm Metab Res; 1982 Jan; 14(1):56. PubMed ID: 6460677
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibody-dependent cell-mediated cytotoxicity (K-cell population) of peripheral lymphocytes in Kawasaki disease and allergic conditions. 1. Relation between K-cell population and the blood immune complex content in Kawasaki disease].
    Suzuki M
    Arerugi; 1983 Mar; 32(3):164-72. PubMed ID: 6625894
    [No Abstract]   [Full Text] [Related]  

  • 28. A syndrome of immunoglobulin A deficiency, diabetes mellitus, malabsorption, a common HLA haplotype. Immunologic and genetic studies of forty-three family members.
    Van Thiel DH; Smith WI; Rabin BS; Fisher SE; Lester R
    Ann Intern Med; 1977 Jan; 86(1):10-9. PubMed ID: 576375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated circulating immune complex level may account for changed ADCC in ophthalmic Graves' patients.
    Nagy E; Kálmán K; Varvölgyi C; Foris G; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):579-82. PubMed ID: 3441607
    [No Abstract]   [Full Text] [Related]  

  • 30. Defective response of natural killer activity to thyroxine in Graves' disease.
    Lee MS; Hong WS; Hong SW; Lee JO; Kang TW
    Korean J Intern Med; 1990 Jul; 5(2):93-6. PubMed ID: 2098098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Natural killer activity in diffuse toxic goiter].
    Shapova EN; Malaĭtsev VV; Bogdanova IM
    Sov Med; 1988; (12):6-8. PubMed ID: 3242120
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibody-mediated cytotoxic activity off circulating lymphocytes directed against human red blood cells in type I and type II diabetes].
    Fövényi J; Garam T; Tótpál K; Thaisz E; Bakács T
    Orv Hetil; 1983 Jun; 124(26):1547-9. PubMed ID: 6604250
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduced intrathyroidal K-cell activity in Graves' disease.
    Bogner U; Schleusener H
    Acta Endocrinol Suppl (Copenh); 1987; 281():96-8. PubMed ID: 3475925
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody-dependent killer-cell function in insulin-dependent diabetes mellitus.
    Ludwig H; Schernthaner G; Kraft D; Scheiner O; Mayr WR
    J Endocrinol Invest; 1980; 3(1):39-44. PubMed ID: 6989889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.
    Struja T; Kutz A; Fischli S; Meier C; Mueller B; Recher M; Schuetz P
    BMC Med; 2017 Sep; 15(1):174. PubMed ID: 28942732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA and Graves' disease or diabetes mellitus in Japan.
    Sasazuki T; Kohno Y; Iwamoto I; Kosaka K; Okimoto K; Maruyama H; Ishiba S; Konishi J; Takeda Y; Naito S
    N Engl J Med; 1978 Mar; 298(11):630-1. PubMed ID: 75503
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for raised K-cell levels in type-I diabetes.
    Pozzilli P; Sensi M; Gorsuch A; Bottazzo GF; Cudworth AG
    Lancet; 1979 Jul; 2(8135):173-5. PubMed ID: 89282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The absence of any effect of methimazole on in vitro cell-mediated cytotoxicity.
    Weetman AP; Gunn C; Hall R; McGregor AM
    Clin Endocrinol (Oxf); 1985 Jan; 22(1):57-64. PubMed ID: 3978828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-dependent and natural killer cytotoxicity in type 1 diabetes.
    Sensi M; Pozzilli P; Cudworth AG
    Acta Diabetol Lat; 1981; 18(4):339-44. PubMed ID: 7331674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are K cells low-affinity E-rosetting cells?
    Early A; Ozer H
    Lancet; 1979 Oct; 2(8145):750. PubMed ID: 90844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.